NEUP (STOCKS)
Neuphoria Therapeutics Inc. Common Stock
$4.290000
-0.150000 (-3.38%)
Prev close: $4.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Spyridon Papapetropoulos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $23.02M
- Employees
- 8
- P/E (TTM)
- -0.18
- P/B (TTM)
- 0.80
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q3)
|
$-0.09 | $-0.99 | +0.8994 | +90.90% |
|
Dec 2025 (Q2)
|
$-0.77 | $-1.49 | +0.7226 | +48.41% |
|
Sep 2025 (Q1)
|
$-4.41 | $-1.35 | -3.0568 | -225.89% |
|
Jun 2025 (Q4)
|
$-5.79 | $-2.12 | -3.6718 | -173.35% |
Financial Statements
| Revenues | -$13.27K |
| Nonoperating Income/Loss | -$1.04M |
| Operating Expenses | $16.75M |
| Depreciation and Amortization | $662.90K |
| Other Operating Expenses | $7.08M |
| Operating Income/Loss | -$16.76M |
| Income/Loss From Continuing Operations After Tax | -$17.46M |
| Income/Loss From Continuing Operations Before Tax | -$17.80M |
| Income Tax Expense/Benefit | -$370.98K |
| Net Income/Loss | -$17.46M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$17.46M |
| Net Income/Loss Available To Common Stockholders, Basic | -$17.46M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$7.90 |
| Diluted Earnings Per Share | -$7.90 |
| Basic Average Shares | 4,151,355 |
| Diluted Average Shares | 4,151,355 |
| Assets | $34.81M |
| Current Assets | $21.66M |
| Prepaid Expenses | $611.91K |
| Other Current Assets | $21.05M |
| Noncurrent Assets | $13.15M |
| Intangible Assets | $4.31M |
| Other Non-current Assets | $8.84M |
| Liabilities | $5.39M |
| Current Liabilities | $1.51M |
| Accounts Payable | $627.19K |
| Other Current Liabilities | $886.12K |
| Noncurrent Liabilities | $3.87M |
| Equity | $29.42M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $29.42M |
| Liabilities And Equity | $34.81M |
| Net Cash Flow From Operating Activities | -$17.15M |
| Net Cash Flow From Operating Activities, Continuing | -$17.15M |
| Net Cash Flow From Investing Activities | -$2.32M |
| Net Cash Flow From Investing Activities, Continuing | -$1.47M |
| Net Cash Flow From Financing Activities | $18.62M |
| Net Cash Flow From Financing Activities, Continuing | $18.62M |
| Exchange Gains/Losses | $852.62K |
| Net Cash Flow | -$852.62K |
| Net Cash Flow, Continuing | -$1.71M |
| Comprehensive Income/Loss | -$15.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$15.59M |
| Other Comprehensive Income/Loss | -$15.38M |
| Other Comprehensive Income/Loss Attributable To Parent | $1.85M |